Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeannette Cany

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cytotherapy|March 22, 2015
Umbilical cord blood-derived cellular products for cancer immunotherapyJeannette Cany, Harry Dolstra, Nina Shah
Journal of Hepatology|April 28, 2007
A transgenic mouse with beta-Galactosidase as a fetal liver self-antigen for immunotherapy studiesJeannette Cany, Audrey Avril, Virginie Pichard, et al.
International Journal of Cancer|May 3, 2014
Agonistic anti-CD137 antibody treatment leads to antitumor response in mice with liver cancerVanessa Gauttier, Jean-Paul Judor, Valentin Le Guen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2009
DNA/amphiphilic block copolymer nanospheres promote low-dose DNA vaccinationDorian McIlroy, Benoît Barteau, Jeannette Cany, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2019
Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Flow CytometryIrene van der Haar Àvila, Patricia Marmol, Jeannette Cany, et al.
Immunotherapy|April 29, 2011
Immunotherapy of hepatocellular carcinoma: is there a place for regulatory T-lymphocyte depletion?Jeannette Cany, Lucile Tran, Vanessa Gauttier, et al.
The Journal of Gene Medicine|October 27, 2011
Differential biodistribution of oncolytic poxvirus administered systemically in an autochthonous model of hepatocellular carcinomaPatrick Baril, Yann Touchefeu, Jeannette Cany, et al.
Oncotarget|October 11, 2014
Multidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemiaSabrina Copsel, Ariana Bruzzone, Maria May, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 10, 2014
Ex vivo generation of interstitial and Langerhans cell-like dendritic cell subset-based vaccines for hematological malignanciesTim Hutten, Soley Thordardottir, Willemijn Hobo, et al.
Journal of Hepatology|October 22, 2010
AFP-specific immunotherapy impairs growth of autochthonous hepatocellular carcinoma in miceJeannette Cany, Benoît Barteau, Lucile Tran, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cytotherapy|March 22, 2015
Umbilical cord blood-derived cellular products for cancer immunotherapyJeannette Cany, Harry Dolstra, Nina Shah
Journal of Hepatology|April 28, 2007
A transgenic mouse with beta-Galactosidase as a fetal liver self-antigen for immunotherapy studiesJeannette Cany, Audrey Avril, Virginie Pichard, et al.
International Journal of Cancer|May 3, 2014
Agonistic anti-CD137 antibody treatment leads to antitumor response in mice with liver cancerVanessa Gauttier, Jean-Paul Judor, Valentin Le Guen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2009
DNA/amphiphilic block copolymer nanospheres promote low-dose DNA vaccinationDorian McIlroy, Benoît Barteau, Jeannette Cany, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2019
Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Flow CytometryIrene van der Haar Àvila, Patricia Marmol, Jeannette Cany, et al.
Immunotherapy|April 29, 2011
Immunotherapy of hepatocellular carcinoma: is there a place for regulatory T-lymphocyte depletion?Jeannette Cany, Lucile Tran, Vanessa Gauttier, et al.
The Journal of Gene Medicine|October 27, 2011
Differential biodistribution of oncolytic poxvirus administered systemically in an autochthonous model of hepatocellular carcinomaPatrick Baril, Yann Touchefeu, Jeannette Cany, et al.
Oncotarget|October 11, 2014
Multidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemiaSabrina Copsel, Ariana Bruzzone, Maria May, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 10, 2014
Ex vivo generation of interstitial and Langerhans cell-like dendritic cell subset-based vaccines for hematological malignanciesTim Hutten, Soley Thordardottir, Willemijn Hobo, et al.
Journal of Hepatology|October 22, 2010
AFP-specific immunotherapy impairs growth of autochthonous hepatocellular carcinoma in miceJeannette Cany, Benoît Barteau, Lucile Tran, et al.
Pageof 2